Breaking News

Targeting gut microbes to reduce cardiovascular risk

The non-antibiotic compounds, tested in animal models, prevented the production of a gut byproduct linked to heart ...

Indivior awards BES £4m design project

The opioid addiction treatment specialist has commissioned the cleanroom designer and fitter to create a new production ...

GEA receives green light for aseptic blow-fill-cap technology

The US Food and Drug Administration has awarded the engineering company a letter of no objection for its integrated ...

Middle East and Africa pharma economy to reach US$38.8 bn by 2021

CPhI Middle East and Africa opens in Abu Dhabi as finished dosage formulations expand quickly, driven by government ...

Combating falsified medicines

ACG Inspection partners with Verinetics to further strengthen the fight against counterfeits

Catalent acquires Juniper Pharmaceuticals

The acquisition will strengthen the technology providers offerings in formulation development and oral dose ...

Health experts reveal 10 most important medicines in NHS history

Antipsychotics, breast cancer drug, oral contraceptives and MMR vaccine make the top 10

Polymers created with light to fight bacteria

Hundreds of polymers, which could kill drug-resistant superbugs in novel ways, can be produced and tested using light ...

Scientists discover compound that targets cancer cells

Developed and tested at the University of Huddersfield, the compound, containing ruthenium, is attracted to vulnerable ...

Freeze drying technology for probiotics and nutraceuticals

Freeze drying is helping meet the demand for probiotics and nutraceuticals across the food and health industries

Treating chronic wounds with live biotherapeutics

Angharad Baldwin talks to Evelina Vågesjö, CEO, and Peter Frank, Drug Development Manager, of Swedish biologics company, ...

Sartorius Stedim Biotech and Siemens: automating the biopharmaceutical industry

With Siemens now a preferred supplier, Sartorius’s product portfolio benefits from a globally standardised automation ...

Manufacturing issue causes limited supply of EpiPens in Canada

Pfizer does not expect to be able to provide new supply until the end of August

Limits of drug repurposing

A new study at Cambridge Judge Business School demonstrates how rare it is to find entirely new uses for existing ...